Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Patricia J. Schlicht, BSN,MA
JCP
Original Research
Benefits of Ashwagandha for Schizophrenia
July 10, 2018
Read a study on how a extract of Ashwagandha (Withania somnifera), when added to antipsychotic medications to patients with schizophrenia.
K. N. Roy Chengappa
,
Jaspreet S. Brar
,
Jessica M. Gannon
, et al
JCP
Original Research
Varenicline for Smoking Cessation in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Study
June 10, 2014
K. N. Roy Chengappa
,
Kenneth A. Perkins
,
Jaspreet S. Brar
, et al
JCP
Original Research
Randomized Placebo-Controlled Adjunctive Study of an Extract of
Withania somnifera
for Cognitive Dysfunction in Bipolar Disorder
November 15, 2013
K. N. Roy Chengappa
,
Christopher R. Bowie
,
Patricia J. Schlicht
, et al
